Figure 3From: Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapyTime-to-local recurrence of HIV-seropositive patients with access to HAART (n = 10) (thin line) and T-/N-stage, age-matched HIV-seronegative patients (n = 10) (thick line) with anal cancer (p = 0.03).Back to article page